 | • レポートコード：MRC2301G132 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、257ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に92.43百万ドルであった世界の血液透析＆腹膜透析市場規模が、2022年に101.29百万ドルに到達し、2027年まで年平均9.84%で成長して162.36百万ドルまで拡大すると予測しています。本レポートは、血液透析＆腹膜透析の世界市場について調べ、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、血液透析製品別（センター用血液透析装置、血液透析用消耗品・用品、血液透析装置、家庭用血液透析装置）分析、溶剤種類別（酸性濃縮液、アルカリ性濃縮液、動静脈グラフト、AVフィスチュラ針・バッグ、その他）分析、モダリティ別（従来型血液透析、夜間血液透析（NHD）、短時間透析）分析、種類別（付属品、セントラル水殺菌装置、化学消毒装置、熱殺菌装置）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など、以下の構成でまとめております。また、Allmed Medical Products Co., Ltd.、AngioDynamics, Inc.、Asahi Kasei Corporation、Atlantic Biomedical Pvt. Ltd.、B. Braun Melsungen AG、Baxter International Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の血液透析＆腹膜透析市場規模：血液透析製品別 - センター用血液透析装置の市場規模 - 血液透析用消耗品・用品の市場規模 - 血液透析装置の市場規模 - 家庭用血液透析装置の市場規模 ・世界の血液透析＆腹膜透析市場規模：溶剤種類別 - 酸性濃縮液における市場規模 - アルカリ性濃縮液における市場規模 - 動静脈グラフトにおける市場規模 - AVフィスチュラ針・バッグにおける市場規模 - その他における市場規模 ・世界の血液透析＆腹膜透析市場規模：モダリティ別 - 従来型血液透析における市場規模 - 夜間血液透析（NHD）における市場規模 - 短時間透析における市場規模 ・世界の血液透析＆腹膜透析市場規模：種類別 - 付属品における市場規模 - セントラル水殺菌装置における市場規模 - 化学消毒装置における市場規模 - 熱殺菌装置における市場規模 ・世界の血液透析＆腹膜透析市場規模：地域別 - 南北アメリカの血液透析＆腹膜透析市場規模 アメリカの血液透析＆腹膜透析市場規模 カナダの血液透析＆腹膜透析市場規模 ブラジルの血液透析＆腹膜透析市場規模 … - アジア太平洋の血液透析＆腹膜透析市場規模 日本の血液透析＆腹膜透析市場規模 中国の血液透析＆腹膜透析市場規模 インドの血液透析＆腹膜透析市場規模 韓国の血液透析＆腹膜透析市場規模 台湾の血液透析＆腹膜透析市場規模 … - ヨーロッパ/中東/アフリカの血液透析＆腹膜透析市場規模 イギリスの血液透析＆腹膜透析市場規模 ドイツの血液透析＆腹膜透析市場規模 フランスの血液透析＆腹膜透析市場規模 ロシアの血液透析＆腹膜透析市場規模 … - その他地域の血液透析＆腹膜透析市場規模 ・競争状況 ・企業情報 |
The Global Hemodialysis & Peritoneal Dialysis Market size was estimated at USD 92.43 million in 2021 and expected to reach USD 101.29 million in 2022, and is projected to grow at a CAGR 9.84% to reach USD 162.36 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Hemodialysis & Peritoneal Dialysis to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Hemodialysis Products, the market was studied across Center-Use Hemodialysis Machines, Hemodialysis Consumables & Supplies, Hemodialysis Machines, and Home-Use Hemodialysis Machines.
Based on Flux Type, the market was studied across Acidic Concentrates, Alkaline Concentrates, Arteriovenous Grafts, AV fistula needle & bags, AV Fistula Needles, Bicarbonate Cartridges, Bloodlines Sets and tubes, Central Venous Catheters, Endotoxin Filters, Hemodialysis Access Products, Hemodialysis Concentrates/Dialysates, Hemodialysis Services, High-Flux Dialyzers, Home Hemodialysis (HHD) Services, In-Center Hemodialysis Services, and low Flux Dialyzers.
Based on Modality, the market was studied across Conventional Hemodialysis, Nocturnal Hemodialysis (NHD), and Short Daily Hemodialysis.
Based on Type, the market was studied across Accessories, Central Water Disinfectant Systems, Chemical Disinfectant Systems, and Heat Disinfectant Systems.
Based on Disease Indication, the market was studied across Acute Kidney Infections, ESRD, Multi-Organ Failure, and Septic Shock.
Based on Dialysis Site, the market was studied across Clinics & Dialysis Centers, Home Dialysis, Home Hemodialysis, Home Peritoneal Dialysis, and Hospitals.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Hemodialysis & Peritoneal Dialysis market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hemodialysis & Peritoneal Dialysis Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hemodialysis & Peritoneal Dialysis Market, including Allmed Medical Products Co., Ltd., AngioDynamics, Inc., Asahi Kasei Corporation, Atlantic Biomedical Pvt. Ltd., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cantel Medical Corporation, DaVita Inc., Dialife SA, Diaverum AB, Fresenius Medical Care AG & Co. KGaA, Isopure Corp., JMS Co., Ltd., Medical Components, Inc., Medtronic plc, Nikkiso Co., Ltd., Nipro Corporation, Rockwell Medical Inc., and Toray Medical Co., Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Hemodialysis & Peritoneal Dialysis Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hemodialysis & Peritoneal Dialysis Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hemodialysis & Peritoneal Dialysis Market?
4. What is the competitive strategic window for opportunities in the Global Hemodialysis & Peritoneal Dialysis Market?
5. What are the technology trends and regulatory frameworks in the Global Hemodialysis & Peritoneal Dialysis Market?
6. What is the market share of the leading vendors in the Global Hemodialysis & Peritoneal Dialysis Market?
7. What modes and strategic moves are considered suitable for entering the Global Hemodialysis & Peritoneal Dialysis Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of ESRD patients
5.1.1.2. Growing prevalence of diabetes and hypertension
5.1.1.3. Shortage of organ donors and risks associated with kidney transplants
5.1.2. Restraints
5.1.2.1. Risks and complications of dialysis due to lack of infrastructure facilities
5.1.3. Opportunities
5.1.3.1. Emergence of new technologically advanced products for the dialysis
5.1.3.2. Increasing investments to develop dialysis centers in the developing economies
5.1.4. Challenges
5.1.4.1. Concerns regarding product recall and reimbursement policies
5.2. Cumulative Impact of COVID-19
6. Hemodialysis & Peritoneal Dialysis Market, by Hemodialysis Products
6.1. Introduction
6.2. Center-Use Hemodialysis Machines
6.3. Hemodialysis Consumables & Supplies
6.4. Hemodialysis Machines
6.5. Home-Use Hemodialysis Machines
7. Hemodialysis & Peritoneal Dialysis Market, by Flux Type
7.1. Introduction
7.2. Acidic Concentrates
7.3. Alkaline Concentrates
7.4. Arteriovenous Grafts
7.5. AV fistula needle & bags
7.6. AV Fistula Needles
7.7. Bicarbonate Cartridges
7.8. Bloodlines Sets and tubes
7.9. Central Venous Catheters
7.10. Endotoxin Filters
7.11. Hemodialysis Access Products
7.12. Hemodialysis Concentrates/Dialysates
7.13. Hemodialysis Services
7.14. High-Flux Dialyzers
7.15. Home Hemodialysis (HHD) Services
7.16. In-Center Hemodialysis Services
7.17. low Flux Dialyzers
8. Hemodialysis & Peritoneal Dialysis Market, by Modality
8.1. Introduction
8.2. Conventional Hemodialysis
8.3. Nocturnal Hemodialysis (NHD)
8.4. Short Daily Hemodialysis
9. Hemodialysis & Peritoneal Dialysis Market, by Type
9.1. Introduction
9.2. Accessories
9.3. Central Water Disinfectant Systems
9.4. Chemical Disinfectant Systems
9.5. Heat Disinfectant Systems
10. Hemodialysis & Peritoneal Dialysis Market, by Disease Indication
10.1. Introduction
10.2. Acute Kidney Infections
10.3. ESRD
10.4. Multi-Organ Failure
10.5. Septic Shock
11. Hemodialysis & Peritoneal Dialysis Market, by Dialysis Site
11.1. Introduction
11.2. Clinics & Dialysis Centers
11.3. Home Dialysis
11.4. Home Hemodialysis
11.5. Home Peritoneal Dialysis
11.6. Hospitals
12. Americas Hemodialysis & Peritoneal Dialysis Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Hemodialysis & Peritoneal Dialysis Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Hemodialysis & Peritoneal Dialysis Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Allmed Medical Products Co., Ltd.
16.1.1. Business Overview
16.1.2. Key Executives
16.1.3. Product & Services
16.2. AngioDynamics, Inc.
16.2.1. Business Overview
16.2.2. Key Executives
16.2.3. Product & Services
16.3. Asahi Kasei Corporation
16.3.1. Business Overview
16.3.2. Key Executives
16.3.3. Product & Services
16.4. Atlantic Biomedical Pvt. Ltd.
16.4.1. Business Overview
16.4.2. Key Executives
16.4.3. Product & Services
16.5. B. Braun Melsungen AG
16.5.1. Business Overview
16.5.2. Key Executives
16.5.3. Product & Services
16.6. Baxter International Inc.
16.6.1. Business Overview
16.6.2. Key Executives
16.6.3. Product & Services
16.7. Becton, Dickinson and Company
16.7.1. Business Overview
16.7.2. Key Executives
16.7.3. Product & Services
16.8. Cantel Medical Corporation
16.8.1. Business Overview
16.8.2. Key Executives
16.8.3. Product & Services
16.9. DaVita Inc.
16.9.1. Business Overview
16.9.2. Key Executives
16.9.3. Product & Services
16.10. Dialife SA
16.10.1. Business Overview
16.10.2. Key Executives
16.10.3. Product & Services
16.11. Diaverum AB
16.11.1. Business Overview
16.11.2. Key Executives
16.11.3. Product & Services
16.12. Fresenius Medical Care AG & Co. KGaA
16.12.1. Business Overview
16.12.2. Key Executives
16.12.3. Product & Services
16.13. Isopure Corp.
16.13.1. Business Overview
16.13.2. Key Executives
16.13.3. Product & Services
16.14. JMS Co., Ltd.
16.14.1. Business Overview
16.14.2. Key Executives
16.14.3. Product & Services
16.15. Medical Components, Inc.
16.15.1. Business Overview
16.15.2. Key Executives
16.15.3. Product & Services
16.16. Medtronic plc
16.16.1. Business Overview
16.16.2. Key Executives
16.16.3. Product & Services
16.17. Nikkiso Co., Ltd.
16.17.1. Business Overview
16.17.2. Key Executives
16.17.3. Product & Services
16.18. Nipro Corporation
16.18.1. Business Overview
16.18.2. Key Executives
16.18.3. Product & Services
16.19. Rockwell Medical Inc.
16.19.1. Business Overview
16.19.2. Key Executives
16.19.3. Product & Services
16.20. Toray Medical Co., Ltd.
16.20.1. Business Overview
16.20.2. Key Executives
16.20.3. Product & Services
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing